Cambridge MedTech Congenica has replaced its CEO.
The precision medicine company – which has built a diagnostic decision support platform for genomic data – has promoted chief information officer Robert Denison to its board and the top job as David Atkins leaves the role.
Congenica, one of our MedTech 50 stars last year, said Atkins had decided it was right time for him to step down, having overseen the growth of Congenica from an ambitious startup to a globally recognised business. He now lists his position as a freelance consultant on LinkedIn.
“David is now pursuing other interests and opportunities and continues to support us,” a spokesperson told BusinessCloud. “He is in close contact with the board and executive team as a valued consultant as Congenica moves through the next phase of its development.”
Atkins wrote on LinkedIn: “Time to make way after ~5 years of having the privilege of leading Congenica in its pursuit of making genomics a routine and integrated contributor to global healthcare.
“The team should be immensely proud of building a business at the interface of incredibly complex biology, technology and clinical science while maintaining an unwavering sense of purpose.
“I’d like to thank Congenica’s customers, partners, collaborators, investors, employees and above all the patients and families that allow it all to happen. I wish the team all the best as they continue to provide life-changing answers.”
MedTech 50 – UK’s most innovative medical technology creators for 2021
Denison joined Congenica as CIO in September 2019 and has led the transformation of Congenica’s core technology into a robust cloud-based diagnostic data analysis and interpretation platform incorporating advanced AI and automation.
The company says he also played a pivotal role in its Series C fundraise of £38 million, which included Tencent.
Denison said: “I am delighted to accept the role of CEO at Congenica, at what is a very exciting time for the business. Congenica is a global leader in genomics data analysis, working with the leading national genome programs and clinical laboratories across the world.
“With an excellent team in place, and supported by a global network of partners, we are well positioned to deliver on our mission of enabling access to precision medicine for all.”
Dr Andy Richards CBE, chairman, added: “Rob is a highly accomplished leader who has demonstrated a deep commitment to Congenica. Under his leadership as CIO, he has positioned Congenica at the forefront of genomics data analysis.”